This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Aspirin vs. low MW heparin for acute stroke in AF

Authoring team

DOUBLE-BLIND RANDOMISED STUDY

20% of all ischaemic strokes are caused by embolism due to atrial fibrillation. Patients with AF who have an ischaemic stroke are at a high risk of recurrent stroke.

This trial compared the efficacy of aspirin and low molecular weight heparin (LMWH) at preventing recurrent stroke within the first 14 days after the first stroke.

Reference:

  • 1) Berge, E, Abdelnoor, M. et al. (2000). Low molecular- weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. Lancet, 355, 1205-10.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.